Pharmacia and Janssen terminate Vestra deal

PHA and Janssen, a wholly owned subsidiary of Johnson & Johnson (JNJ), mutually terminated their U.S. co-promotion deal for PHA's Vestra reboxetine antidepressant. In February, PHA received a second a...